Verrica Pharmaceuticals (VRCA) Earnings Date & Reports

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

VRCA is expected to report earnings to fall 55.21% to -10 cents per share on May 07

Verrica Pharmaceuticals VRCA Stock Earnings Reports

Q1'25

Est.

$-0.11

Q4'24

Beat

by $0.06

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.05

The last earnings report on March 11 showed earnings per share of -23 cents, beating the estimate of -30 cents. With 356.67K shares outstanding, the current market capitalization sits at 38.55M.

View a ticker or compare two or three

Compare

VRCA